Crossmark

Semaphorin-3A: a promising therapeutic tool in allergic rhinitis

Crossref DOI link: https://doi.org/10.1007/s12026-022-09264-1

Published Online: 2022-01-14

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lotfi, Ramin https://orcid.org/0000-0002-5421-5280
Zamanimehr, Nahid
License Information

Text and Data Mining valid from 2022-01-14

Version of Record valid from 2022-01-14
More Information

Article History

Received: 8 November 2021

Accepted: 10 January 2022

First Online: 14 January 2022

Declarations

:

: The authors declare no competing interests.